UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

Advances in therapy, 2017-02, Vol.34 (2), p.300-323

Karalis, Dean G.

2017

Volltextzugriff (PDF)

The risks of statin use in pregnancy: A systematic review

Journal of clinical lipidology, 2016-09, Vol.10 (5), p.1081-1090

2016

Volltextzugriff (PDF)

Gender Differences in Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease

The American journal of cardiology, 2014-05, Vol.113 (10), p.1611-1615

2014

Volltextzugriff (PDF)

Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease

Current opinion in lipidology, 2023-12, Vol.34 (6), p.252-258

Karalis, Dean G.

2023

Volltextzugriff (PDF)

Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.833-841

2016

Volltextzugriff (PDF)

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia

Journal of clinical medicine, 2023-02, Vol.12 (4), p.1382

2023

Volltextzugriff (PDF)

Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association

Journal of clinical lipidology, 2017-07, Vol.11 (4), p.891-900

2017

Volltextzugriff (PDF)

Editorial commentary: Advances in the management of dyslipidemia: The future is bright, but what we do today is what matters most

Trends in cardiovascular medicine, 2021-10, Vol.31 (7), p.425-426

Karalis, Dean G.

2021

Volltextzugriff (PDF)

Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease

Journal of clinical medicine, 2021-08, Vol.10 (17), p.3828

2021

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease

American journal of preventive cardiology, 2023-06, Vol.14, p.100499-100499, Article 100499

2023

Volltextzugriff (PDF)

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease

Clinical cardiology (Mahwah, N.J.), 2023-01, Vol.46 (1), p.13-21

2023

Volltextzugriff (PDF)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia

Journal of clinical medicine, 2021-07, Vol.10 (14), p.3090

2021

Volltextzugriff (PDF)

Are statins safe in patients with COVID-19?

Journal of clinical lipidology, 2020-07, Vol.14 (4), p.396-397

Karalis, Dean G.

2020

Volltextzugriff (PDF)

Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease

The American journal of cardiology, 2011-03, Vol.107 (6), p.886-890

2011

Volltextzugriff (PDF)

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease

The American journal of cardiology, 2009-10, Vol.104 (8), p.1052-1054

2009

Volltextzugriff (PDF)

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients

Cholesterol, 2012-01, Vol.2012 (2012), p.1-7

2012

Volltextzugriff (PDF)

Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association

Journal of general internal medicine : JGIM, 2020-07, Vol.35 (7), p.2225-2227

2020

Volltextzugriff (PDF)

Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical Trials

Lipid Insights, 2013, Vol.2013 (2013), p.13-20

2013

Volltextzugriff (PDF)

Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association

Journal of general internal medicine : JGIM, 2020-10

2020

Volltextzugriff (PDF)

Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia

The American journal of cardiology, 2018-05, Vol.121 (10), p.1155-1161

2018

Volltextzugriff (PDF)

Achieving optimal lipid goals in the metabolic syndrome: A global health problem

Atherosclerosis, 2014-11, Vol.237 (1), p.191-193

Karalis, Dean G

2014

Volltextzugriff (PDF)

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease

Mayo Clinic proceedings, 2009-04, Vol.84 (4), p.345-352

Karalis, Dean G.

2009

Volltextzugriff (PDF)

Effect of health information technology interventions on lipid management in clinical practice: A systematic review of randomized controlled trials

Journal of clinical lipidology, 2013-11, Vol.7 (6), p.546-560

2013

Volltextzugriff (PDF)

Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists)

The American journal of cardiology, 2021-08, Vol.152, p.57-62

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(78)
Berichte
(1)

Sprache

Englisch
(79)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(55)
Science & Technology
(55)
Humans
(52)
Male
(33)
Cardiovascular System & Cardiology
(32)
Biological And Medical Sciences
(29)
Cardiac & Cardiovascular Systems
(29)
Medical Sciences
(29)
Female
(28)
Aged
(24)
Middle Aged
(22)
Adult
(16)
Cardiology. Vascular System
(16)
Statins
(16)
Risk Factors
(14)
Cholesterol
(12)
Echocardiography
(12)
Hydroxymethylglutaryl-Coa Reductase Inhibitors - Therapeutic Use
(12)
Lipids
(12)
Pharmacology & Pharmacy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Review of Clinical Practice Guidelines for the Management of Hypertriglyceridemia: A Focus on High Dose Omega-3 Fatty Acids

The risks of statin use in pregnancy: A systematic review

Gender Differences in Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease

Strategies of improving adherence to lipid-lowering therapy in patients with atherosclerotic cardiovascular disease

Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia

Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association

Editorial commentary: Advances in the management of dyslipidemia: The future is bright, but what we do today is what matters most

Trends in PCSK9 Inhibitor Prescriptions before and after the Price Reduction in Patients with Atherosclerotic Cardiovascular Disease

Impact of the COVID-19 pandemic on the management of risk factors in patients with stable atherosclerotic vascular disease

Nonadherence to lipid‐lowering therapy and strategies to improve adherence in patients with atherosclerotic cardiovascular disease

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia

Are statins safe in patients with COVID-19?

Achieving Optimal Lipid Goals in Patients With Coronary Artery Disease

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease

Use of Lipid-Lowering Medications and the Likelihood of Achieving Optimal LDL-Cholesterol Goals in Coronary Artery Disease Patients

Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association

Do Omega-3 Polyunsaturated Fatty Acids Prevent Cardiovascular Disease? A Review of the Randomized Clinical Trials

Correction to: Recognition and Treatment of Homozygous Familial Hypercholesterolemia by Primary Care Physicians: a Survey from the National Lipid Association

Prescribing Patterns of Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors in Eligible Patients With Clinical Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia

Achieving optimal lipid goals in the metabolic syndrome: A global health problem

Intensive Lowering of Low-Density Lipoprotein Cholesterol Levels for Primary Prevention of Coronary Artery Disease

Effect of health information technology interventions on lipid management in clinical practice: A systematic review of randomized controlled trials

Perceptions and Barriers on the Use of Proprotein Subtilisin/Kexin Type 9 Inhibitors in Heterozygous Familial Hypercholesterolemia (From a Survey of Primary Care Physicians and Cardiologists)

Use of health information technology (HIT) to improve statin adherence and low-density lipoprotein cholesterol goal attainment in high-risk patients: Proceedings from a workshop

Suchergebnisse filtern